Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial

Introduction Medication adherence and inhaler technique in patients with asthma remain suboptimal. A digital, smart spacer may support personalised adherence and inhaler technique education. The aim of this study is to assess the feasibility of undertaking a definitive randomised controlled trial of...

Full description

Saved in:
Bibliographic Details
Main Authors: Job F. M. van Boven, Boudewijn H.J. Dierick, Maria Achterbosch, Sandra Been-Buck, Titia Klemmeier, Susanne J. van de Hei, Paul Hagedoorn, Huib A.M. Kerstjens, Janwillem W.H. Kocks
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e059929.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583722765910016
author Job F. M. van Boven
Boudewijn H.J. Dierick
Maria Achterbosch
Sandra Been-Buck
Titia Klemmeier
Susanne J. van de Hei
Paul Hagedoorn
Huib A.M. Kerstjens
Janwillem W.H. Kocks
author_facet Job F. M. van Boven
Boudewijn H.J. Dierick
Maria Achterbosch
Sandra Been-Buck
Titia Klemmeier
Susanne J. van de Hei
Paul Hagedoorn
Huib A.M. Kerstjens
Janwillem W.H. Kocks
author_sort Job F. M. van Boven
collection DOAJ
description Introduction Medication adherence and inhaler technique in patients with asthma remain suboptimal. A digital, smart spacer may support personalised adherence and inhaler technique education. The aim of this study is to assess the feasibility of undertaking a definitive randomised controlled trial of personalised, smart spacer data-driven education and explore clinical benefits.Methods and analysis We present the design of the multicentre, randomised controlled OUtcomes following Tailored Education and Retraining: Studying Performance and AdherenCE feasibility trial of 2 months. Patients will be recruited from four Dutch general practices. At t=−1, patients with asthma ≥18 years using inhaled corticosteroids±long-acting beta-agonists±short-acting beta-agonists administered with a pressurised-metered-dose-inhaler and spacer (n=40) will use a smart spacer for 1 month. The rechargeable CE-marked smart spacer (Aerochamber Plus with Flow Vu) includes a sensor that monitors adherence and inhalation technique to prescribed dosing regimen of both maintenance and reliever inhalers. After 1 month (t=0), patients are 1:1 randomised into two groups: control group (usual care) versus intervention group (personalised education). At t=-1, t=0 and t=1 month, the Asthma Control Questionnaire (ACQ), Work Productivity and Activity Impairment (WPAI) questionnaire and Test of Adherence to Inhalers (TAI) are administered and fractional exhaled nitric oxide (FeNO) is assessed. At t=0 and t=1, spirometry is performed. At t=1, usability and satisfaction will be analysed using the System Usability Scale and interviews with patients and healthcare providers. Primary outcome is the overall feasibility of a definitive trial assessed by patient recruitment speed, participation and drop-out rate. Secondary outcomes are patient and healthcare provider satisfaction and exploratory clinical outcomes are adherence, inhaler technique, TAI score, FeNO, lung function, ACQ and WPAI.Ethics and dissemination Ethical approval was obtained from the RTPO in Leeuwarden, Netherlands (number: NL78361.099.21). Patients will provide written informed consent. Study findings will be disseminated through conferences and peer-reviewed scientific and professional journals.Trial registration number NL9637.
format Article
id doaj-art-79d662388d954c4fa59755d80e7f5e47
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-79d662388d954c4fa59755d80e7f5e472025-01-28T06:45:11ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-059929Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trialJob F. M. van Boven0Boudewijn H.J. Dierick1Maria Achterbosch2Sandra Been-Buck3Titia Klemmeier4Susanne J. van de Hei5Paul Hagedoorn6Huib A.M. Kerstjens7Janwillem W.H. Kocks8Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsDepartment of Pulmonology, Martini Hospital, Groningen, The NetherlandsDepartment of Pulmonology, Martini Hospital, Groningen, The NetherlandsGroningen Research Institute for Asthma and COPD (GRIAC), Groningen, The NetherlandsPharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, Groningen, The NetherlandsGroningen Research Institute for Asthma and COPD (GRIAC), Groningen, The NetherlandsMedication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The NetherlandsIntroduction Medication adherence and inhaler technique in patients with asthma remain suboptimal. A digital, smart spacer may support personalised adherence and inhaler technique education. The aim of this study is to assess the feasibility of undertaking a definitive randomised controlled trial of personalised, smart spacer data-driven education and explore clinical benefits.Methods and analysis We present the design of the multicentre, randomised controlled OUtcomes following Tailored Education and Retraining: Studying Performance and AdherenCE feasibility trial of 2 months. Patients will be recruited from four Dutch general practices. At t=−1, patients with asthma ≥18 years using inhaled corticosteroids±long-acting beta-agonists±short-acting beta-agonists administered with a pressurised-metered-dose-inhaler and spacer (n=40) will use a smart spacer for 1 month. The rechargeable CE-marked smart spacer (Aerochamber Plus with Flow Vu) includes a sensor that monitors adherence and inhalation technique to prescribed dosing regimen of both maintenance and reliever inhalers. After 1 month (t=0), patients are 1:1 randomised into two groups: control group (usual care) versus intervention group (personalised education). At t=-1, t=0 and t=1 month, the Asthma Control Questionnaire (ACQ), Work Productivity and Activity Impairment (WPAI) questionnaire and Test of Adherence to Inhalers (TAI) are administered and fractional exhaled nitric oxide (FeNO) is assessed. At t=0 and t=1, spirometry is performed. At t=1, usability and satisfaction will be analysed using the System Usability Scale and interviews with patients and healthcare providers. Primary outcome is the overall feasibility of a definitive trial assessed by patient recruitment speed, participation and drop-out rate. Secondary outcomes are patient and healthcare provider satisfaction and exploratory clinical outcomes are adherence, inhaler technique, TAI score, FeNO, lung function, ACQ and WPAI.Ethics and dissemination Ethical approval was obtained from the RTPO in Leeuwarden, Netherlands (number: NL78361.099.21). Patients will provide written informed consent. Study findings will be disseminated through conferences and peer-reviewed scientific and professional journals.Trial registration number NL9637.https://bmjopen.bmj.com/content/12/6/e059929.full
spellingShingle Job F. M. van Boven
Boudewijn H.J. Dierick
Maria Achterbosch
Sandra Been-Buck
Titia Klemmeier
Susanne J. van de Hei
Paul Hagedoorn
Huib A.M. Kerstjens
Janwillem W.H. Kocks
Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
BMJ Open
title Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
title_full Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
title_fullStr Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
title_full_unstemmed Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
title_short Can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma?: Protocol of the randomised controlled OUTERSPACE trial
title_sort can electronic monitoring with a digital smart spacer support personalised medication adherence and inhaler technique education in patients with asthma protocol of the randomised controlled outerspace trial
url https://bmjopen.bmj.com/content/12/6/e059929.full
work_keys_str_mv AT jobfmvanboven canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT boudewijnhjdierick canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT mariaachterbosch canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT sandrabeenbuck canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT titiaklemmeier canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT susannejvandehei canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT paulhagedoorn canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT huibamkerstjens canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial
AT janwillemwhkocks canelectronicmonitoringwithadigitalsmartspacersupportpersonalisedmedicationadherenceandinhalertechniqueeducationinpatientswithasthmaprotocoloftherandomisedcontrolledouterspacetrial